Eli Lilly & Co. (LLY) Misses Q1 EPS by 12c; updates guidance

Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $3.34, $0.12 worse than the analyst estimate of $3.46. Revenue for the quarter came in at $12.73 billion versus the consensus estimate of $12.72 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2025 EPS of $20.78-$22.28, versus the consensus of $22.40. Eli Lilly & Co. sees FY2025 revenue of $58-61 billion, versus the consensus of $59.57 billion.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.

You May Also Be Interested In

• BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
• H.C. Wainwright Assumes Alpha Compute Corp. (ALP) at Neutral
• Home Depot (HD) call put ratio 1.3 calls to 1 put into quarter results